Amprius Technologies, Inc. (AMPX)
(Delayed Data from NYSE)
$0.87 USD
+0.07 (8.08%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.89 +0.02 (1.73%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.87 USD
+0.07 (8.08%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.89 +0.02 (1.73%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Zacks News
Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of -18.18% and 36.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Bitfarms (BITF) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Bitfarms' (BITF) second-quarter 2024 revenues are likely to have increased year over year, whereas earnings are expected to have declined.
Arbe Robotics Ltd. (ARBE) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Industrial Tech Acquisitions (ARBE) delivered earnings and revenue surprises of 18.18% and 104.50%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Amprius Technologies (AMPX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amprius (AMPX) delivered earnings and revenue surprises of 0% and 37.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Bitfarms Ltd. (BITF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Bitfarms (BITF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amprius Technologies (AMPX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Amprius (AMPX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Amprius Technologies (AMPX) Ahead of Earnings?
by Zacks Equity Research
Amprius Technologies (AMPX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat Likely for Micron Technology (MU) in Q2 Earnings?
by Zacks Equity Research
Micron Technology's (MU) Q2 performance is likely to have benefited from the strong demand for memory chips used for GPU-enabled AI servers, along with an improving supply-demand environment and higher prices for DRAM and NAND.
Amprius Technologies (AMPX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Amprius (AMPX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Revenue Decline Impact Jabil's (JBL) Q2 Earnings?
by Zacks Equity Research
Jabil (JBL) is expected to report a top-line contraction year over year in the second quarter of fiscal 2024, owing to soft demand trends in several business segments.
Can Amprius (AMPX) Climb 137.2% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 137.2% in Amprius (AMPX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Best Momentum Stocks to Buy for January 10th
by Zacks Equity Research
IMCR, CPRX and AMPX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 10, 2024.
New Strong Buy Stocks for January 10th
by Zacks Equity Research
PCRFY, IMCR, CPRX, AMPX and ENS have been added to the Zacks Rank #1 (Strong Buy) List on January 10, 2024.
How Amprius (AMPX) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Amprius (AMPX) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
OppFi (OPFI) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
OppFi (OPFI) is likely to witness a year-over-year increase in revenues and earnings in the third quarter of 2023.
AirSculpt (AIRS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
AirSculpt (AIRS) is likely to witness year-over-year increases in revenues and earnings in the third quarter of 2023.
Shift4 Payments (FOUR) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Shift4 Payments' (FOUR) third-quarter 2023 earnings and revenues are expected to increase year over year.
Duolingo (DUOL) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Duolingo (DUOL) is likely to have witnessed a year-over-year increase in revenues in the third quarter of 2023.
Amprius Technologies (AMPX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Amprius (AMPX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amprius (AMPX) Stock Jumps 27.3%: Will It Continue to Soar?
by Zacks Equity Research
Amprius (AMPX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.